401k Plan data: BARTELL DRUG COMPANY 401(K) PLAN plan

BARTELL DRUG COMPANY 401(K) PLAN 401k Plan overview

Plan Name	BARTELL DRUG COMPANY 401(K) PLAN
Plan identification number	003

BARTELL DRUG COMPANY 401(K) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

BARTELL DRUG COMPANY has sponsored the creation of one or more 401k plans.

Company Name: BARTELL DRUG COMPANY

Employer identification number (EIN): 910138195

NAIC Classification: 446110
NAIC Description: Pharmacies and Drug Stores

Additional information about BARTELL DRUG COMPANY

Jurisdiction of Incorporation: Washington Secretary of State Corporations Division

Incorporation Date: 1904-01-23

Company Identification Number: 178003963

Legal Registered Office Address: 711 CAPITOL WAY S STE 204

OLYMPIA
United States of America (USA)
985011267

More information about BARTELL DRUG COMPANY

Form 5500 Filing Information

Submission information for form 5500 for 401k plan BARTELL DRUG COMPANY 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
003 2021-01-01
003 2020-01-01
003 2020-01-01
003 2019-01-01
003 2018-01-01
003 2017-01-01 KELLY KENNEDY
003 2016-01-01 JEFF DEL ROSARIO
003 2015-01-01 JOHN J SULLIVAN JOHN J SULLIVAN 2016-10-17
003 2014-01-01 JOHN J. SULLIVAN JOHN J. SULLIVAN 2015-10-14
003 2013-01-01 JOHN J. SULLIVAN JOHN J. SULLIVAN 2014-10-15
003 2012-01-01 JOHN J. SULLIVAN
003 2011-01-01 JOHN SULLIVAN
003 2010-01-01 JOHN J. SULLIVAN
003 2009-01-01 JOHN J. SULLIVAN JOHN J. SULLIVAN 2010-10-13

Plan id#	Filing Submission Date	Name of Administrator	Name of Company Sponsor	Date Sponsor Signed
003	2021-01-01
003	2020-01-01
003	2020-01-01
003	2019-01-01
003	2018-01-01
003	2017-01-01	KELLY KENNEDY
003	2016-01-01	JEFF DEL ROSARIO
003	2015-01-01	JOHN J SULLIVAN	JOHN J SULLIVAN	2016-10-17
003	2014-01-01	JOHN J. SULLIVAN	JOHN J. SULLIVAN	2015-10-14
003	2013-01-01	JOHN J. SULLIVAN	JOHN J. SULLIVAN	2014-10-15
003	2012-01-01	JOHN J. SULLIVAN
003	2011-01-01	JOHN SULLIVAN
003	2010-01-01	JOHN J. SULLIVAN
003	2009-01-01	JOHN J. SULLIVAN	JOHN J. SULLIVAN	2010-10-13

Plan Statistics for BARTELL DRUG COMPANY 401(K) PLAN

401k plan membership statisitcs for BARTELL DRUG COMPANY 401(K) PLAN

Measure Date Value
2021: BARTELL DRUG COMPANY 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 1,952
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 0
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 0
Total of all active and inactive participants 2021-01-01 0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 0
Number of participants with account balances 2021-01-01 0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 0
2020: BARTELL DRUG COMPANY 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 2,121
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 1,454
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 1,951
Total of all active and inactive participants 2020-01-01 3,405
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 1
Total participants 2020-01-01 3,406
Number of participants with account balances 2020-01-01 1,952
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: BARTELL DRUG COMPANY 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 1,972
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 1,337
Number of retired or separated participants receiving benefits 2019-01-01 8
Number of other retired or separated participants entitled to future benefits 2019-01-01 775
Total of all active and inactive participants 2019-01-01 2,120
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 1
Total participants 2019-01-01 2,121
Number of participants with account balances 2019-01-01 2,121
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: BARTELL DRUG COMPANY 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 1,990
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 1,427
Number of retired or separated participants receiving benefits 2018-01-01 12
Number of other retired or separated participants entitled to future benefits 2018-01-01 532
Total of all active and inactive participants 2018-01-01 1,971
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 1
Total participants 2018-01-01 1,972
Number of participants with account balances 2018-01-01 1,852
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0
2017: BARTELL DRUG COMPANY 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 1,856
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 1,514
Number of retired or separated participants receiving benefits 2017-01-01 16
Number of other retired or separated participants entitled to future benefits 2017-01-01 459
Total of all active and inactive participants 2017-01-01 1,989
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 1
Total participants 2017-01-01 1,990
Number of participants with account balances 2017-01-01 1,893
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 0
2016: BARTELL DRUG COMPANY 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 1,827
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 1,508
Number of retired or separated participants receiving benefits 2016-01-01 12
Number of other retired or separated participants entitled to future benefits 2016-01-01 336
Total of all active and inactive participants 2016-01-01 1,856
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 1,856
Number of participants with account balances 2016-01-01 1,694
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: BARTELL DRUG COMPANY 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 1,788
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 1,512
Number of retired or separated participants receiving benefits 2015-01-01 12
Number of other retired or separated participants entitled to future benefits 2015-01-01 303
Total of all active and inactive participants 2015-01-01 1,827
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 1,827
Number of participants with account balances 2015-01-01 1,638
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 0
2014: BARTELL DRUG COMPANY 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 1,670
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 1,519
Number of retired or separated participants receiving benefits 2014-01-01 13
Number of other retired or separated participants entitled to future benefits 2014-01-01 256
Total of all active and inactive participants 2014-01-01 1,788
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 1,788
Number of participants with account balances 2014-01-01 1,603
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 0
2013: BARTELL DRUG COMPANY 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 1,638
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 1,447
Number of retired or separated participants receiving benefits 2013-01-01 9
Number of other retired or separated participants entitled to future benefits 2013-01-01 214
Total of all active and inactive participants 2013-01-01 1,670
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 1,670
Number of participants with account balances 2013-01-01 1,520
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 0
2012: BARTELL DRUG COMPANY 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 1,634
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 1,430
Number of retired or separated participants receiving benefits 2012-01-01 6
Number of other retired or separated participants entitled to future benefits 2012-01-01 202
Total of all active and inactive participants 2012-01-01 1,638
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 1,638
Number of participants with account balances 2012-01-01 1,477
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 0
2011: BARTELL DRUG COMPANY 401(K) PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 1,479
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 1,440
Number of retired or separated participants receiving benefits 2011-01-01 4
Number of other retired or separated participants entitled to future benefits 2011-01-01 190
Total of all active and inactive participants 2011-01-01 1,634
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 0
Total participants 2011-01-01 1,634
Number of participants with account balances 2011-01-01 1,461
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 0
2010: BARTELL DRUG COMPANY 401(K) PLAN 2010 401k membership
Total participants, beginning-of-year 2010-01-01 1,491
Total number of active participants reported on line 7a of the Form 5500 2010-01-01 1,309
Number of retired or separated participants receiving benefits 2010-01-01 3
Number of other retired or separated participants entitled to future benefits 2010-01-01 167
Total of all active and inactive participants 2010-01-01 1,479
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2010-01-01 0
Total participants 2010-01-01 1,479
Number of participants with account balances 2010-01-01 1,356
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2010-01-01 0
2009: BARTELL DRUG COMPANY 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 2,237
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 1,313
Number of retired or separated participants receiving benefits 2009-01-01 2
Number of other retired or separated participants entitled to future benefits 2009-01-01 175
Total of all active and inactive participants 2009-01-01 1,490
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 1
Total participants 2009-01-01 1,491
Number of participants with account balances 2009-01-01 1,301
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 0

Measure	Date	Value
2021: BARTELL DRUG COMPANY 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	1,952
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	0
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	0
Total of all active and inactive participants	2021-01-01	0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	0
Number of participants with account balances	2021-01-01	0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	0
2020: BARTELL DRUG COMPANY 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	2,121
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	1,454
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	1,951
Total of all active and inactive participants	2020-01-01	3,405
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	1
Total participants	2020-01-01	3,406
Number of participants with account balances	2020-01-01	1,952
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: BARTELL DRUG COMPANY 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	1,972
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	1,337
Number of retired or separated participants receiving benefits	2019-01-01	8
Number of other retired or separated participants entitled to future benefits	2019-01-01	775
Total of all active and inactive participants	2019-01-01	2,120
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	1
Total participants	2019-01-01	2,121
Number of participants with account balances	2019-01-01	2,121
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: BARTELL DRUG COMPANY 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	1,990
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	1,427
Number of retired or separated participants receiving benefits	2018-01-01	12
Number of other retired or separated participants entitled to future benefits	2018-01-01	532
Total of all active and inactive participants	2018-01-01	1,971
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	1
Total participants	2018-01-01	1,972
Number of participants with account balances	2018-01-01	1,852
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0
2017: BARTELL DRUG COMPANY 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	1,856
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	1,514
Number of retired or separated participants receiving benefits	2017-01-01	16
Number of other retired or separated participants entitled to future benefits	2017-01-01	459
Total of all active and inactive participants	2017-01-01	1,989
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	1
Total participants	2017-01-01	1,990
Number of participants with account balances	2017-01-01	1,893
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	0
2016: BARTELL DRUG COMPANY 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	1,827
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	1,508
Number of retired or separated participants receiving benefits	2016-01-01	12
Number of other retired or separated participants entitled to future benefits	2016-01-01	336
Total of all active and inactive participants	2016-01-01	1,856
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	1,856
Number of participants with account balances	2016-01-01	1,694
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: BARTELL DRUG COMPANY 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	1,788
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	1,512
Number of retired or separated participants receiving benefits	2015-01-01	12
Number of other retired or separated participants entitled to future benefits	2015-01-01	303
Total of all active and inactive participants	2015-01-01	1,827
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	1,827
Number of participants with account balances	2015-01-01	1,638
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	0
2014: BARTELL DRUG COMPANY 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	1,670
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	1,519
Number of retired or separated participants receiving benefits	2014-01-01	13
Number of other retired or separated participants entitled to future benefits	2014-01-01	256
Total of all active and inactive participants	2014-01-01	1,788
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	1,788
Number of participants with account balances	2014-01-01	1,603
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	0
2013: BARTELL DRUG COMPANY 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	1,638
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	1,447
Number of retired or separated participants receiving benefits	2013-01-01	9
Number of other retired or separated participants entitled to future benefits	2013-01-01	214
Total of all active and inactive participants	2013-01-01	1,670
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	1,670
Number of participants with account balances	2013-01-01	1,520
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	0
2012: BARTELL DRUG COMPANY 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	1,634
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	1,430
Number of retired or separated participants receiving benefits	2012-01-01	6
Number of other retired or separated participants entitled to future benefits	2012-01-01	202
Total of all active and inactive participants	2012-01-01	1,638
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	1,638
Number of participants with account balances	2012-01-01	1,477
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	0
2011: BARTELL DRUG COMPANY 401(K) PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	1,479
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	1,440
Number of retired or separated participants receiving benefits	2011-01-01	4
Number of other retired or separated participants entitled to future benefits	2011-01-01	190
Total of all active and inactive participants	2011-01-01	1,634
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	0
Total participants	2011-01-01	1,634
Number of participants with account balances	2011-01-01	1,461
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	0
2010: BARTELL DRUG COMPANY 401(K) PLAN 2010 401k membership
Total participants, beginning-of-year	2010-01-01	1,491
Total number of active participants reported on line 7a of the Form 5500	2010-01-01	1,309
Number of retired or separated participants receiving benefits	2010-01-01	3
Number of other retired or separated participants entitled to future benefits	2010-01-01	167
Total of all active and inactive participants	2010-01-01	1,479
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2010-01-01	0
Total participants	2010-01-01	1,479
Number of participants with account balances	2010-01-01	1,356
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2010-01-01	0
2009: BARTELL DRUG COMPANY 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	2,237
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	1,313
Number of retired or separated participants receiving benefits	2009-01-01	2
Number of other retired or separated participants entitled to future benefits	2009-01-01	175
Total of all active and inactive participants	2009-01-01	1,490
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	1
Total participants	2009-01-01	1,491
Number of participants with account balances	2009-01-01	1,301
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	0

Financial Data on BARTELL DRUG COMPANY 401(K) PLAN

Measure	Date	Value
2021 : BARTELL DRUG COMPANY 401(K) PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-08-05	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-08-05	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-08-05	$972,915
Total income from all sources (including contributions)	2021-08-05	$4,783,476
Total loss/gain on sale of assets	2021-08-05	$0
Total of all expenses incurred	2021-08-05	$109,063,175
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-08-05	$108,773,051
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-08-05	$100,000
Value of total assets at end of year	2021-08-05	$0
Value of total assets at beginning of year	2021-08-05	$105,252,614
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-08-05	$290,124
Total interest from all sources	2021-08-05	$951
Total dividends received (eg from common stock, registered investment company shares)	2021-08-05	$64,125
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-08-05	Yes
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan	2021-08-05	$0
Total dividends received from registered investment company shares (eg mutual funds)	2021-08-05	$64,125
Administrative expenses professional fees incurred	2021-08-05	$290,124
Was this plan covered by a fidelity bond	2021-08-05	Yes
Value of fidelity bond cover	2021-08-05	$500,000
If this is an individual account plan, was there a blackout period	2021-08-05	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-08-05	$0
Were there any nonexempt tranactions with any party-in-interest	2021-08-05	No
Participant contributions at end of year	2021-08-05	$0
Participant contributions at beginning of year	2021-08-05	$904,571
Income. Received or receivable in cash from other sources (including rollovers)	2021-08-05	$100,000
Other income not declared elsewhere	2021-08-05	$135
Liabilities. Value of operating payables at end of year	2021-08-05	$0
Liabilities. Value of operating payables at beginning of year	2021-08-05	$5,810
Total non interest bearing cash at end of year	2021-08-05	$0
Total non interest bearing cash at beginning of year	2021-08-05	$608,596
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-08-05	No
Value of net income/loss	2021-08-05	$-104,279,699
Value of net assets at end of year (total assets less liabilities)	2021-08-05	$0
Value of net assets at beginning of year (total assets less liabilities)	2021-08-05	$104,279,699
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-08-05	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-08-05	No
Were any leases to which the plan was party in default or uncollectible	2021-08-05	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-08-05	$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-08-05	$98,271,385
Interest on participant loans	2021-08-05	$951
Value of interest in common/collective trusts at end of year	2021-08-05	$0
Value of interest in common/collective trusts at beginning of year	2021-08-05	$5,468,062
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-08-05	$4,618,265
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-08-05	No
Was there a failure to transmit to the plan any participant contributions	2021-08-05	No
Has the plan failed to provide any benefit when due under the plan	2021-08-05	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-08-05	$108,773,051
Liabilities. Value of benefit claims payable at end of year	2021-08-05	$0
Liabilities. Value of benefit claims payable at beginning of year	2021-08-05	$967,105
Did the plan have assets held for investment	2021-08-05	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-08-05	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-08-05	Yes
Opinion of an independent qualified public accountant for this plan	2021-08-05	Unqualified
Accountancy firm name	2021-08-05	CLARK NUBER P.S.
Accountancy firm EIN	2021-08-05	911194016
2020 : BARTELL DRUG COMPANY 401(K) PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$972,915
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$13,828
Total income from all sources (including contributions)	2020-12-31	$20,226,980
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$14,030,626
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$13,774,182
Value of total corrective distributions	2020-12-31	$22,037
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$4,199,632
Value of total assets at end of year	2020-12-31	$105,252,614
Value of total assets at beginning of year	2020-12-31	$98,097,173
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$234,407
Total interest from all sources	2020-12-31	$52,246
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$4,836,088
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	Yes
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan	2020-12-31	$0
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$4,836,088
Administrative expenses professional fees incurred	2020-12-31	$234,407
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$4,186,060
Participant contributions at end of year	2020-12-31	$904,571
Participant contributions at beginning of year	2020-12-31	$1,134,002
Participant contributions at end of year	2020-12-31	$0
Participant contributions at beginning of year	2020-12-31	$1,994
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$13,572
Other income not declared elsewhere	2020-12-31	$1,929
Liabilities. Value of operating payables at end of year	2020-12-31	$5,810
Liabilities. Value of operating payables at beginning of year	2020-12-31	$430
Total non interest bearing cash at end of year	2020-12-31	$608,596
Total non interest bearing cash at beginning of year	2020-12-31	$14,258
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$6,196,354
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$104,279,699
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$98,083,345
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$98,271,385
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$92,188,187
Interest on participant loans	2020-12-31	$52,246
Value of interest in common/collective trusts at end of year	2020-12-31	$5,468,062
Value of interest in common/collective trusts at beginning of year	2020-12-31	$4,758,732
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$11,028,010
Net investment gain or loss from common/collective trusts	2020-12-31	$109,075
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$809
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$13,774,182
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2020-12-31	Yes
Liabilities. Value of benefit claims payable at end of year	2020-12-31	$967,105
Liabilities. Value of benefit claims payable at beginning of year	2020-12-31	$13,398
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Accountancy firm name	2020-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2020-12-31	911194016
2019 : BARTELL DRUG COMPANY 401(K) PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$13,828
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$1,020
Total income from all sources (including contributions)	2019-12-31	$23,572,419
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$9,556,176
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$9,364,870
Value of total corrective distributions	2019-12-31	$22,916
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$4,299,718
Value of total assets at end of year	2019-12-31	$98,097,173
Value of total assets at beginning of year	2019-12-31	$84,068,122
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$168,390
Total interest from all sources	2019-12-31	$62,381
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$1,783,694
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$1,783,694
Administrative expenses professional fees incurred	2019-12-31	$168,390
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$4,288,123
Participant contributions at end of year	2019-12-31	$1,134,002
Participant contributions at beginning of year	2019-12-31	$1,127,059
Participant contributions at end of year	2019-12-31	$1,994
Participant contributions at beginning of year	2019-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$11,595
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2019-12-31	$2,865
Other income not declared elsewhere	2019-12-31	$4,522
Liabilities. Value of operating payables at end of year	2019-12-31	$430
Liabilities. Value of operating payables at beginning of year	2019-12-31	$566
Total non interest bearing cash at end of year	2019-12-31	$14,258
Total non interest bearing cash at beginning of year	2019-12-31	$201,345
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$14,016,243
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$98,083,345
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$84,067,102
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$92,188,187
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$77,309,248
Interest on participant loans	2019-12-31	$61,381
Interest earned on other investments	2019-12-31	$1,000
Value of interest in common/collective trusts at end of year	2019-12-31	$4,758,732
Value of interest in common/collective trusts at beginning of year	2019-12-31	$5,430,470
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$17,302,920
Net investment gain or loss from common/collective trusts	2019-12-31	$119,184
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$9,362,005
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2019-12-31	Yes
Liabilities. Value of benefit claims payable at end of year	2019-12-31	$13,398
Liabilities. Value of benefit claims payable at beginning of year	2019-12-31	$454
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2019-12-31	911194016
2018 : BARTELL DRUG COMPANY 401(K) PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$1,020
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$1,964,180
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$15,507,549
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$15,374,426
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$5,708,263
Value of total assets at end of year	2018-12-31	$84,068,122
Value of total assets at beginning of year	2018-12-31	$97,610,471
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$133,123
Total interest from all sources	2018-12-31	$57,368
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$4,544,632
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$4,544,632
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$500,000
If this is an individual account plan, was there a blackout period	2018-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$4,739,832
Participant contributions at end of year	2018-12-31	$1,127,059
Participant contributions at beginning of year	2018-12-31	$1,120,983
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$141,142
Other income not declared elsewhere	2018-12-31	$-578
Administrative expenses (other) incurred	2018-12-31	$133,123
Liabilities. Value of operating payables at end of year	2018-12-31	$566
Liabilities. Value of operating payables at beginning of year	2018-12-31	$0
Total non interest bearing cash at end of year	2018-12-31	$201,345
Total non interest bearing cash at beginning of year	2018-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-13,543,369
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$84,067,102
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$97,610,471
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$77,309,248
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$90,370,501
Interest on participant loans	2018-12-31	$56,500
Value of interest in common/collective trusts at end of year	2018-12-31	$5,430,470
Value of interest in common/collective trusts at beginning of year	2018-12-31	$6,118,987
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2018-12-31	$868
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-8,485,398
Net investment gain or loss from common/collective trusts	2018-12-31	$139,893
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$827,289
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$15,374,426
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2018-12-31	Yes
Liabilities. Value of benefit claims payable at end of year	2018-12-31	$454
Liabilities. Value of benefit claims payable at beginning of year	2018-12-31	$0
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2018-12-31	911194016
2017 : BARTELL DRUG COMPANY 401(K) PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$20,353,955
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$5,845,861
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$5,668,904
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$5,413,191
Value of total assets at end of year	2017-12-31	$97,610,471
Value of total assets at beginning of year	2017-12-31	$83,102,377
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$176,957
Total interest from all sources	2017-12-31	$50,517
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$3,839,923
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$3,839,923
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$4,381,486
Participant contributions at end of year	2017-12-31	$1,120,983
Participant contributions at beginning of year	2017-12-31	$1,124,194
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$267,772
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2017-12-31	$1,133
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2017-12-31	$0
Other income not declared elsewhere	2017-12-31	$15,506
Administrative expenses (other) incurred	2017-12-31	$176,957
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$14,508,094
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$97,610,471
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$83,102,377
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$90,370,501
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$74,693,201
Interest on participant loans	2017-12-31	$50,517
Value of interest in common/collective trusts at end of year	2017-12-31	$6,118,987
Value of interest in common/collective trusts at beginning of year	2017-12-31	$7,284,982
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$10,910,369
Net investment gain or loss from common/collective trusts	2017-12-31	$124,449
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$763,933
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$5,667,771
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2017-12-31	911194016
2016 : BARTELL DRUG COMPANY 401(K) PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$38,522
Total income from all sources (including contributions)	2016-12-31	$11,426,535
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$8,440,498
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$8,354,475
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$4,801,021
Value of total assets at end of year	2016-12-31	$83,102,377
Value of total assets at beginning of year	2016-12-31	$80,154,862
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$86,023
Total interest from all sources	2016-12-31	$47,538
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$2,867,248
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$2,867,248
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$4,038,767
Participant contributions at end of year	2016-12-31	$1,124,194
Participant contributions at beginning of year	2016-12-31	$1,217,192
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$21,756
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2016-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2016-12-31	$38,522
Other income not declared elsewhere	2016-12-31	$53,159
Administrative expenses (other) incurred	2016-12-31	$86,023
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$2,986,037
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$83,102,377
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$80,116,340
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$74,693,201
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$73,709,150
Interest on participant loans	2016-12-31	$47,538
Value of interest in common/collective trusts at end of year	2016-12-31	$7,284,982
Value of interest in common/collective trusts at beginning of year	2016-12-31	$5,228,520
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$3,539,833
Net investment gain or loss from common/collective trusts	2016-12-31	$117,736
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$740,498
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$8,354,475
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2016-12-31	911194016
2015 : BARTELL DRUG COMPANY 401(K) PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$38,522
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$33,512
Total income from all sources (including contributions)	2015-12-31	$4,795,883
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$6,887,525
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$6,827,202
Expenses. Certain deemed distributions of participant loans	2015-12-31	$8,395
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$4,889,030
Value of total assets at end of year	2015-12-31	$80,154,862
Value of total assets at beginning of year	2015-12-31	$82,241,494
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$51,928
Total interest from all sources	2015-12-31	$47,632
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$3,135,480
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$3,135,480
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$3,948,983
Participant contributions at end of year	2015-12-31	$1,217,192
Participant contributions at beginning of year	2015-12-31	$1,119,706
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$207,412
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2015-12-31	$38,522
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2015-12-31	$33,512
Other income not declared elsewhere	2015-12-31	$5,365
Administrative expenses (other) incurred	2015-12-31	$51,928
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$-2,091,642
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$80,116,340
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$82,207,982
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$73,709,150
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$75,579,760
Interest on participant loans	2015-12-31	$47,632
Value of interest in common/collective trusts at end of year	2015-12-31	$5,228,520
Value of interest in common/collective trusts at beginning of year	2015-12-31	$5,542,028
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-3,217,483
Net investment gain or loss from common/collective trusts	2015-12-31	$-64,141
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$732,635
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$6,827,202
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2015-12-31	911194016
2014 : BARTELL DRUG COMPANY 401(K) PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$33,512
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$11,125
Total income from all sources (including contributions)	2014-12-31	$11,912,105
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$8,393,893
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$8,294,998
Expenses. Certain deemed distributions of participant loans	2014-12-31	$45,538
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$4,664,264
Value of total assets at end of year	2014-12-31	$82,241,494
Value of total assets at beginning of year	2014-12-31	$78,700,895
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$53,357
Total interest from all sources	2014-12-31	$53,077
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$3,878,135
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$3,878,135
Administrative expenses professional fees incurred	2014-12-31	$44,643
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$3,739,475
Participant contributions at end of year	2014-12-31	$1,119,706
Participant contributions at beginning of year	2014-12-31	$1,227,787
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$254,098
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2014-12-31	$747
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2014-12-31	$33,512
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2014-12-31	$11,125
Administrative expenses (other) incurred	2014-12-31	$8,714
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$3,518,212
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$82,207,982
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$78,689,770
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$75,579,760
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$71,735,103
Interest on participant loans	2014-12-31	$53,077
Value of interest in common/collective trusts at end of year	2014-12-31	$5,542,028
Value of interest in common/collective trusts at beginning of year	2014-12-31	$5,738,005
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$3,208,347
Net investment gain or loss from common/collective trusts	2014-12-31	$108,282
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$670,691
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$8,294,251
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2014-12-31	911194016
2013 : BARTELL DRUG COMPANY 401(K) PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets	2013-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$11,125
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$18,684,236
Total loss/gain on sale of assets	2013-12-31	$0
Total of all expenses incurred	2013-12-31	$6,926,190
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$6,879,673
Expenses. Certain deemed distributions of participant loans	2013-12-31	$1,966
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$4,340,127
Value of total assets at end of year	2013-12-31	$78,700,895
Value of total assets at beginning of year	2013-12-31	$66,931,724
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$44,551
Total interest from all sources	2013-12-31	$50,017
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$2,939,658
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2013-12-31	$2,939,658
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$3,471,774
Participant contributions at end of year	2013-12-31	$1,227,787
Participant contributions at beginning of year	2013-12-31	$1,138,812
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$194,879
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2013-12-31	$11,125
Other income not declared elsewhere	2013-12-31	$7,898
Administrative expenses (other) incurred	2013-12-31	$44,551
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$11,758,046
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$78,689,770
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$66,931,724
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$71,735,103
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$59,785,150
Interest on participant loans	2013-12-31	$50,017
Value of interest in common/collective trusts at end of year	2013-12-31	$5,738,005
Value of interest in common/collective trusts at beginning of year	2013-12-31	$6,007,762
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$11,090,888
Net investment gain or loss from common/collective trusts	2013-12-31	$255,648
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$673,474
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$6,879,673
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2013-12-31	911194016
2012 : BARTELL DRUG COMPANY 401(K) PLAN 2012 401k financial data
Total unrealized appreciation/depreciation of assets	2012-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$15,290
Total income from all sources (including contributions)	2012-12-31	$11,287,364
Total loss/gain on sale of assets	2012-12-31	$0
Total of all expenses incurred	2012-12-31	$3,380,351
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$3,336,268
Expenses. Certain deemed distributions of participant loans	2012-12-31	$1,686
Value of total corrective distributions	2012-12-31	$2,493
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$4,140,600
Value of total assets at end of year	2012-12-31	$66,931,724
Value of total assets at beginning of year	2012-12-31	$59,040,001
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$39,904
Total interest from all sources	2012-12-31	$48,358
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$1,526,747
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2012-12-31	$1,526,747
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$3,306,453
Participant contributions at end of year	2012-12-31	$1,138,812
Participant contributions at beginning of year	2012-12-31	$1,047,807
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$232,640
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2012-12-31	$799
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2012-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2012-12-31	$15,290
Other income not declared elsewhere	2012-12-31	$4,293
Administrative expenses (other) incurred	2012-12-31	$39,904
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$7,907,013
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$66,931,724
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$59,024,711
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-12-31	$59,785,150
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-12-31	$51,624,264
Interest on participant loans	2012-12-31	$48,358
Value of interest in common/collective trusts at end of year	2012-12-31	$6,007,762
Value of interest in common/collective trusts at beginning of year	2012-12-31	$6,367,930
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$5,728,949
Net investment gain or loss from common/collective trusts	2012-12-31	$-161,583
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$601,507
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$3,335,469
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2012-12-31	911194016
2011 : BARTELL DRUG COMPANY 401(K) PLAN 2011 401k financial data
Total unrealized appreciation/depreciation of assets	2011-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$15,290
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$12,225
Total income from all sources (including contributions)	2011-12-31	$3,828,842
Total loss/gain on sale of assets	2011-12-31	$0
Total of all expenses incurred	2011-12-31	$2,691,953
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-12-31	$2,640,651
Expenses. Certain deemed distributions of participant loans	2011-12-31	$12,837
Value of total corrective distributions	2011-12-31	$16
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-12-31	$3,371,355
Value of total assets at end of year	2011-12-31	$59,040,001
Value of total assets at beginning of year	2011-12-31	$57,900,047
Total of administrative expenses incurred including professional, contract, advisory and management fees	2011-12-31	$38,449
Total interest from all sources	2011-12-31	$45,287
Total dividends received (eg from common stock, registered investment company shares)	2011-12-31	$1,401,936
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2011-12-31	$1,401,936
Was this plan covered by a fidelity bond	2011-12-31	Yes
Value of fidelity bond cover	2011-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2011-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2011-12-31	No
Contributions received from participants	2011-12-31	$3,040,471
Participant contributions at end of year	2011-12-31	$1,047,807
Participant contributions at beginning of year	2011-12-31	$879,749
Income. Received or receivable in cash from other sources (including rollovers)	2011-12-31	$1,912
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2011-12-31	$2,036
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2011-12-31	$15,290
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2011-12-31	$12,225
Other income not declared elsewhere	2011-12-31	$3,065
Administrative expenses (other) incurred	2011-12-31	$38,449
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Value of net income/loss	2011-12-31	$1,136,889
Value of net assets at end of year (total assets less liabilities)	2011-12-31	$59,024,711
Value of net assets at beginning of year (total assets less liabilities)	2011-12-31	$57,887,822
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-12-31	No
Were any leases to which the plan was party in default or uncollectible	2011-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2011-12-31	$51,624,264
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2011-12-31	$52,158,761
Interest on participant loans	2011-12-31	$45,287
Value of interest in common/collective trusts at end of year	2011-12-31	$6,367,930
Value of interest in common/collective trusts at beginning of year	2011-12-31	$4,861,537
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2011-12-31	$-1,247,694
Net investment gain or loss from common/collective trusts	2011-12-31	$254,893
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-12-31	No
Was there a failure to transmit to the plan any participant contributions	2011-12-31	No
Has the plan failed to provide any benefit when due under the plan	2011-12-31	No
Contributions received in cash from employer	2011-12-31	$328,972
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-12-31	$2,638,615
Did the plan have assets held for investment	2011-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2011-12-31	Disclaimer
Accountancy firm name	2011-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2011-12-31	911194016
2010 : BARTELL DRUG COMPANY 401(K) PLAN 2010 401k financial data
Total unrealized appreciation/depreciation of assets	2010-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$12,225
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$9,183
Total income from all sources (including contributions)	2010-12-31	$9,779,767
Total loss/gain on sale of assets	2010-12-31	$0
Total of all expenses incurred	2010-12-31	$2,780,167
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$2,739,115
Expenses. Certain deemed distributions of participant loans	2010-12-31	$3,660
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$3,790,979
Value of total assets at end of year	2010-12-31	$57,900,047
Value of total assets at beginning of year	2010-12-31	$50,897,405
Total of administrative expenses incurred including professional, contract, advisory and management fees	2010-12-31	$37,392
Total interest from all sources	2010-12-31	$43,380
Total dividends received (eg from common stock, registered investment company shares)	2010-12-31	$1,129,614
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2010-12-31	$1,129,614
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$5,000,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$3,083,693
Participant contributions at end of year	2010-12-31	$879,749
Participant contributions at beginning of year	2010-12-31	$765,823
Participant contributions at end of year	2010-12-31	$0
Participant contributions at beginning of year	2010-12-31	$73,986
Income. Received or receivable in cash from other sources (including rollovers)	2010-12-31	$232,171
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2010-12-31	$438
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2010-12-31	$12,225
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2010-12-31	$9,183
Administrative expenses (other) incurred	2010-12-31	$37,392
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$6,999,600
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$57,887,822
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$50,888,222
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$52,158,761
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$45,395,529
Interest on participant loans	2010-12-31	$43,380
Value of interest in common/collective trusts at end of year	2010-12-31	$4,861,537
Value of interest in common/collective trusts at beginning of year	2010-12-31	$4,590,747
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2010-12-31	$4,586,902
Net investment gain or loss from common/collective trusts	2010-12-31	$228,892
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	No
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Contributions received in cash from employer	2010-12-31	$475,115
Employer contributions (assets) at end of year	2010-12-31	$0
Employer contributions (assets) at beginning of year	2010-12-31	$71,320
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$2,738,677
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2010-12-31	No
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	CLARK NUBER P.S.
Accountancy firm EIN	2010-12-31	911194016

Form 5500 Responses for BARTELL DRUG COMPANY 401(K) PLAN

2021: BARTELL DRUG COMPANY 401(K) PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	Yes
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: BARTELL DRUG COMPANY 401(K) PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: BARTELL DRUG COMPANY 401(K) PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: BARTELL DRUG COMPANY 401(K) PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: BARTELL DRUG COMPANY 401(K) PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: BARTELL DRUG COMPANY 401(K) PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: BARTELL DRUG COMPANY 401(K) PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: BARTELL DRUG COMPANY 401(K) PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: BARTELL DRUG COMPANY 401(K) PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: BARTELL DRUG COMPANY 401(K) PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: BARTELL DRUG COMPANY 401(K) PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Submission has been amended	No
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan is a collectively bargained plan	No
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes
2010: BARTELL DRUG COMPANY 401(K) PLAN 2010 form 5500 responses
2010-01-01	Type of plan entity	Single employer plan
2010-01-01	Submission has been amended	No
2010-01-01	This submission is the final filing	No
2010-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2010-01-01	Plan is a collectively bargained plan	No
2010-01-01	Plan funding arrangement – Trust	Yes
2010-01-01	Plan benefit arrangement - Trust	Yes
2009: BARTELL DRUG COMPANY 401(K) PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	BARTELL DRUG COMPANY
Employer identification number (EIN):	910138195
NAIC Classification:	446110
NAIC Description:	Pharmacies and Drug Stores

Jurisdiction of Incorporation:	Washington Secretary of State Corporations Division
Incorporation Date:	1904-01-23
Company Identification Number:	178003963
Legal Registered Office Address:	711 CAPITOL WAY S STE 204 OLYMPIA United States of America (USA) 985011267